BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 27544322)

  • 41. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertension in children with congenital adrenal hyperplasia.
    Maccabee-Ryaboy N; Thomas W; Kyllo J; Lteif A; Petryk A; Gonzalez-Bolanos MT; Hindmarsh PC; Sarafoglou K
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):528-34. PubMed ID: 27105393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and management of classical congenital adrenal hyperplasia.
    Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
    Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
    Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
    Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S; Sellers EA; Guyda H;
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L; Huamei M; Zhe S; Yanhong L; Hongshan C; Qiuli C; Jun Z; Song G; Minlian D
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):841-8. PubMed ID: 27054598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnosis of the adrenogenital syndrome caused by 11beta-hydroxylase deficiency using gas chromatographic-mass spectrometric analysis of the urinary steroid profile].
    Wudy SA; Homoki J; Wachter UA; Teller WM
    Dtsch Med Wochenschr; 1997 Jan; 122(1-2):3-10; discussion 11. PubMed ID: 9064231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W; Schmidt H; Schwarz HP
    Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
    Deslauriers JR; Lenz AM; Root AW; Diamond FB; Bercu BB
    J Pediatr Endocrinol Metab; 2012; 25(9-10):977-81. PubMed ID: 23426829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced activity of 11β-hydroxylase accounts for elevated 17α-hydroxyprogesterone in preterms.
    Kamrath C; Hartmann MF; Boettcher C; Wudy SA
    J Pediatr; 2014 Aug; 165(2):280-4. PubMed ID: 24862381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
    Bacila I; Freeman N; Daniel E; Sandrk M; Bryce J; Ali SR; Yavas Abali Z; Atapattu N; Bachega TA; Balsamo A; Birkebæk N; Blankenstein O; Bonfig W; Cools M; Costa EC; Darendeliler F; Einaudi S; Elsedfy HH; Finken M; Gevers E; Claahsen-van der Grinten HL; Guran T; Güven A; Hannema SE; Higham CE; Iotova V; van der Kamp HJ; Korbonits M; Krone RE; Lichiardopol C; Luczay A; Mendonca BB; Milenkovic T; Miranda MC; Mohnike K; Neumann U; Ortolano R; Poyrazoglu S; Thankamony A; Tomlinson JW; Vieites A; de Vries L; Ahmed SF; Ross RJ; Krone NP
    Eur J Endocrinol; 2021 Apr; 184(4):553-563. PubMed ID: 33460392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.
    Reisch N; Idkowiak J; Hughes BA; Ivison HE; Abdul-Rahman OA; Hendon LG; Olney AH; Nielsen S; Harrison R; Blair EM; Dhir V; Krone N; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E528-36. PubMed ID: 23365120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary 17 alpha-hydroxyprogesterone in management of 21-hydroxylase deficiency.
    Lim YJ; Yong AB; Warne GL; Montalto J
    J Paediatr Child Health; 1995 Feb; 31(1):47-50. PubMed ID: 7748691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W; Kaufhold A; Willgerodt H; Keller E
    Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The balance of cortisol-cortisone interconversion is shifted towards cortisol in neonates with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Kamrath C; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2014 Sep; 143():386-91. PubMed ID: 24861266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
    Völkl TM; Rauh M; Schöfl C; Dörr HG
    Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.